patch-clamp technique

patch-clamp technique
Name	patch-clamp technique
Caption	Glass micropipette forming a seal with a cell membrane
Invented by	Erwin Neher; Bert Sakmann
Year	1976–1981
Field	Electrophysiology
Keywords	single-channel recording; whole-cell recording; gigaseal

Contents

patch-clamp technique

The patch-clamp technique is an experimental method for recording ionic currents through individual ion channels and across cellular membranes using a glass micropipette. Developed to resolve single-channel conductance with high temporal and voltage resolution, the method bridged disciplines and influenced research at institutions such as Max Planck Society, University of Göttingen, Harvard University, Massachusetts Institute of Technology, and Stanford University. Early recognition included awards and attention linked to figures associated with the Nobel Prize in Physiology or Medicine and laboratories influenced by scientists affiliated with Rockefeller University and University of Zurich.

History and Development

The development of the technique traces to work by Erwin Neher and Bert Sakmann in the 1970s and early 1980s at research environments connected to Max Planck Society and collaborations reaching laboratories like Columbia University and University of Basel. Funding and institutional support arose from agencies and foundations such as the Deutsche Forschungsgemeinschaft, National Institutes of Health, and historical research programs associated with Wellcome Trust and Howard Hughes Medical Institute. The method evolved alongside technological advances at companies and institutions including Siemens, Amgen, Oxford Instruments, and university engineering groups at California Institute of Technology and Imperial College London. Seminal demonstrations of single-channel currents altered projects at centers like Johns Hopkins University, University of Cambridge, Yale University, and University College London, and influenced curricula at University of California, San Francisco and McGill University.

Patch-clamp recording uses a polished glass micropipette connected to an amplifier to measure transmembrane current under controlled voltage or current conditions; core concepts were formalized in theoretical work from groups at Princeton University, University of Chicago, University of Oxford, Brown University, and University of Pennsylvania. Major recording configurations include cell-attached, inside-out, outside-out, whole-cell, and perforated-patch modes—approaches refined in laboratories at Duke University, University of Michigan, University of California, Berkeley, Karolinska Institutet, and University of Freiburg. Achieving the high-resistance "gigaseal" employs techniques practiced in training courses at Cold Spring Harbor Laboratory, EMBL, and industry workshops by Molecular Devices and HEKA Elektronik. Theoretical underpinnings relate to models and analyses developed by researchers affiliated with Bell Labs, Los Alamos National Laboratory, MIT Lincoln Laboratory, and Max Planck Institute for Biophysical Chemistry.

Typical setups combine micromanipulators, micropipette pullers, vibration isolation, and low-noise amplifiers from vendors and engineering groups connected to National Institutes of Health, European Space Agency, NASA, and equipment manufacturers like Molecular Devices, HEKA Elektronik, and Warner Instruments. Micropipettes are fabricated on pullers developed at facilities such as Sutter Instrument and calibrated in cleanrooms influenced by standards from National Institute of Standards and Technology and Fraunhofer Society. Amplifiers and headstages trace design lineages to engineering teams at Texas Instruments, Analog Devices, Stanford Linear Accelerator Center, and university electronics shops at ETH Zurich. Environmental control and imaging often integrate optics from companies and labs tied to Zeiss, Nikon, Olympus Corporation, and microscopy centers at University of California, San Diego and Mount Sinai Health System.

Patch-clamp recording revolutionized studies of neuronal excitability, synaptic transmission, and cardiac electrophysiology, influencing research groups at Columbia University, Salk Institute, Max Delbrück Center, RIKEN, and Monell Chemical Senses Center. It provided key data for understanding channels such as voltage-gated sodium and potassium channels studied at Howard Hughes Medical Institute-funded labs and for investigations into ligand-gated receptors in projects at National Institutes of Health, Pasteur Institute, and Karolinska Institutet. Clinical and translational applications engaged centers like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and biotechnology firms including Genentech and Biogen. The technique underpinned discoveries documented in major journals associated with Nature Publishing Group, Cell Press, Proceedings of the National Academy of Sciences, and The Lancet.

Data acquisition relies on high-bandwidth digitizers and analysis suites developed by companies and computational groups at MathWorks, National Instruments, IBM Research, Microsoft Research, and university bioinformatics centers at Broad Institute and European Bioinformatics Institute. Signal processing draws on methods from researchers at Bell Labs, Carnegie Mellon University, University of Toronto, and ETH Zurich for filtering, deconvolution, and event detection. Statistical interpretation often references frameworks and collaborators at Princeton University, Harvard University, Stanford University, Yale University, and bioengineering departments at Johns Hopkins University and Georgia Institute of Technology.

Limitations include access to intact tissues in clinical sites such as Mayo Clinic and Cleveland Clinic, space-clamp issues encountered by electrophysiology groups at University of California, Irvine and University of Washington, and recording stability constraints discussed in consortia involving NIH BRAIN Initiative and European projects funded through Horizon 2020. Artifacts from series resistance, liquid junction potentials, and seal instability are practical concerns handled in protocols developed at Cold Spring Harbor Laboratory, Max Planck Institute for Medical Research, and technical workshops sponsored by Society for Neuroscience and Biophysical Society.

Extensions include automated high-throughput patch-clamp platforms created by companies and consortia with ties to Amgen, AstraZeneca, Pfizer, GlaxoSmithKline, and academic spin-offs from Karolinska Institutet, Imperial College London, and University of Cambridge. Combinations with optogenetics pioneered in labs affiliated with MIT, Harvard Medical School, University College London, Stanford University, and University of California, San Francisco allow millisecond control of membrane potential. Hybrid methods integrate patch-clamp with imaging and molecular tools developed by groups at HHMI Janelia Research Campus, Cold Spring Harbor Laboratory, Max Planck Institute for Neurobiology, Salk Institute, and RIKEN.